In Peripheral Spondyloarthritis, Early Biologic Needed In Peripheral Spondyloarthritis, Early Biologic Needed

New data from the CRESPA extension study show that the addition of methotrexate during biologic tapering has no significant effect on remission in peripheral spondyloarthritis.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news